Stock Events

Alnylam Pharmaceuticals (ALNY) Q2 2023 Earnings

4MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-2.69
-2.26
-1.83
-1.4

Details

Expected EPS
-1.79
Actual EPS
-1.4
Surprise EPS
0.39
Surprise Percent
+21.79%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.4 per share for Q2 2023.

0 Comments

Share your thoughts